Add Yahoo as a preferred source to see more of our stories on Google. Illustration: Cat O'Neil/The Guardian I first took beta blockers two years ago, when I was asked to give a eulogy. Terrible at ...

Beta-blockers may not reduce the risk of death or repeat heart attacks for patients with preserved heart function. Women may face higher risks from beta-blockers. Long-term use can cause side effects ...

Propranolol has become a confidence boost to a generation of women seeking a one-stop cure to a hectic life. Is it so bad? Or ...

A large 2025 trial found the standard post-heart-attack pill made no difference for patients with normal pumping function, ...

A new review in World Journal of Pediatrics argues that despite the transformative impact of beta blockers, ulcerated ...

In a recent study, beta blockers appeared to significantly lower both the annualized risk for conversion from presymptomatic to symptomatic Huntington disease (HD) and the rate of worsening among ...

Share on Pinterest Experts say beta-blockers are essential medications for a number of heart-related conditions. Shikhar Bhattarai/Stocksy Beta-blockers are used to treat heart problems and high blood ...

Add Yahoo as a preferred source to see more of our stories on Google. A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood ...

Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with ...

Beta-blockers provide no clinical benefit to post-MI patients with preserved left ventricular ejection fraction, according to a potentially paradigm-changing meta-analysis. The findings, published ...

One way or another, beta blockers are always in the news. Take, for instance, Los Angeles Chargers Head Coach Jim Harbaugh, who revealed in October that he's part of a growing group of Americans who ...

For 40 years, it has been the standard in post-heart attack health care, but a new study from the European Society of Cardiology is putting the usage of beta blockers in limbo. While the new study may ...